00024 - MRK - Merck & Co Inc

MRK NYSE: 104.10 USD on 2023-03-17
Country: USA - 5620104010.0 : Pharmaceuticals (NEC)
sectors - other companies... - Yahoo!- Roic

gauge graph for MRK
mktcap_usd=264268
ConsensRecom=1.89
earning_yield=3.89%
growth=6.64%
dilution=-1.53%
div_ratio=50.33%
sh_payout_ratio=88.99%
margin=17.71%
cfmargin=16.90%
ratiopaid=83.63%
sratiopaid=25.07%
ratioConsens=1.15

Description

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services for the prevention, treatment and control of disease in all major livestock and companion animal species.

Income and Cashflow Statements USD

EndDate 2016-12-31 2017-12-31 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 mean std
sourceDate 2019-02-27 2019-02-27 2019-02-27 2022-02-25 2022-02-25 2022-02-25 2023-02-24 NaN NaN
period 12M 12M 12M 12M 12M 12M 12M NaN NaN
rev 39807 40122 42294 39121 41518 48704 59283 44407 7303
revgrowth NaN 0.79% 5.27% -7.80% 5.95% 15.96% 19.66% 6.64% 10.01%
earn 3920 2394 6220 9843 7067 13049 14519 8145 4534
earnx 3920 5019 6509 5690 4519 12345 14519 7503 4180
margin 9.85% 5.97% 14.71% 25.16% 17.02% 26.79% 24.49% 17.71% 8.10%
xmargin 9.85% 12.51% 15.39% 14.54% 10.88% 25.35% 24.49% 16.14% 6.30%
earningyld 2.44% 1.58% 3.19% 4.41% 3.57% 6.72% 5.24% 3.88% 1.74%
cfop 10376 6447 10922 13440 10253 14109 19095 12092 3968
cfinv -3210 2679 4314 -2629 -9443 -16555 -4960 -4258 7117
cffin -9044 -10006 -13160 -8861 -2832 2593 -9119 -7204 5295
cfopmargin 26.07% 16.07% 25.82% 34.35% 24.70% 28.97% 32.21% 26.88% 5.95%
cfinvmargin -8.06% 6.68% 10.20% -6.72% -22.74% -33.99% -8.37% -9.00% 15.46%
cffinmargin -22.72% -24.94% -31.12% -22.65% -6.82% 5.32% -15.38% -16.90% 12.46%
shares 2783 2744 2675 2577 2538 2535 2539 2627 106
fx 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0
price 57.6 55.1 72.9 86.7 78.0 76.6 109 76.6 18.3
dilution NaN -1.41% -2.54% -3.77% -1.52% -0.12% 0.16% -1.53% 1.48%
dividend 5124 5167 5172 5695 6215 6610 7012 5856 768
sharebb NaN 2195 4408 7889 3208 232 -371 2926 3019
ltdebtbb NaN 2921 1547 -2930 -2624 -5330 1945 -745 3324
mgtbb NaN 277 -2033 1793 3967 4105 -533 1262 2479
divyld 3.20% 3.42% 2.65% 2.55% 3.14% 3.40% 2.53% 2.98% 0.40%
sharebbyld NaN 1.41% 2.54% 3.77% 1.52% 0.12% -0.16% 1.53% 1.48%
mgtyld NaN 0.18% -1.04% 0.80% 2.00% 2.11% -0.19% 0.64% 1.25%

Balance Sheet

EndDate 2016-12-31 2017-12-31 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 mean std
sourceDate 2019-02-27 2019-02-27 2019-02-27 2022-02-25 2022-02-25 2022-02-25 2023-02-24 NaN NaN
mktcap 160372 151141 194922 223440 197923 194252 277164 199887 41881
mktcapgrowth NaN -5.93% 25.44% 13.65% -12.13% -1.87% 35.55% 9.12% 18.89%
totAsset 95377 87872 82637 84397 91588 105694 109160 93818 10271
assetgrowth NaN -8.20% -6.14% 2.11% 8.18% 14.32% 3.23% 2.25% 8.50%
curAsset 30614 24766 25875 27483 27764 30266 35722 28927 3671
curAssetPct 32.10% 28.18% 31.31% 32.56% 30.31% 28.64% 32.72% 30.83% 1.85%
totLiab 55289 53536 55936 58490 66271 67510 63169 60029 5606
totLiabPct 57.97% 60.92% 67.69% 69.30% 72.36% 63.87% 57.87% 64.28% 5.69%
curLiab 17204 18614 22206 22220 27327 23872 24239 22240 3441
curLiabPct 18.04% 21.18% 26.87% 26.33% 29.84% 22.59% 22.21% 23.86% 4.01%
ltDebt 24274 21353 19806 22736 25360 30690 28745 24709 3913
ltDebtPct 25.45% 24.30% 23.97% 26.94% 27.69% 29.04% 26.33% 26.25% 1.82%
Equity 40088 34336 26701 25907 25317 38184 45991 33789 8086
EquityPct 42.03% 39.08% 32.31% 30.70% 27.64% 36.13% 42.13% 35.72% 5.69%
PB 4.00 4.40 7.30 8.62 7.82 5.09 6.03 6.18 1.78
price graph for MRK price graph for MRK price graph for MRK price graph for MRK

Beta

len=131
mean=8.55%
sd=17.92%
alpha=0.96%
beta=30.23%
r_sq=7.28%
lastdate=2023-03-17
firstdate=2013-01-31
logret1y=23.80%

Financial Snapshot

CompanyName=Merck & Co Inc
ID=1
Name=Ordinary Shares
Ticker=MRK
ISIN=None
RIC=MRK
DisplayRIC=MRK.N
InstrumentPI=264638
QuotePI=1090732
InstrumentPermID=8590923036
QuotePermID=55838324217
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-07
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=69000
SharesOut=2.539e+09
TotalFloat=2.533e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=104
NHIG=115
NLOW=78.6
PDATE=2023-03-17
VOL10DAVG=12.3
EV=281766
MKTCAP=264268
AREV=59283
AEBITD=27923
ANIAC=14519
AEPSXCLXOR=5.71
AREVPS=23.3
ABVPS=18.1
ACSHPS=5.20
ACFSHR=7.25
ADIVSHR=2.80
AGROSMGN=71.0
AROEPCT=34.5
APR2REV=4.46
APEEXCLXOR=18.2
APRICE2BK=5.74
ConsRecom=1.89
TargetPrice=120
ProjLTGrowthRate=10.9
ProjPE=15.1
ProjSales=58218
ProjSalesQ=13835
ProjEPS=6.89
ProjEPSQ=1.35
ProjProfit=17530
ProjDPS=2.98
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None

Valuation

ticker=MRK
exchg=AMEX
RIC=MRK
CompanyName=Merck & Co Inc
ExchangeCode=NYSE
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=264268
float_usd=263650
ConsensRecom=1.89
earning_yield=3.89%
growth=6.64%
dilution=-1.53%
margin=17.71%
searning_yield=2.24%
sgrowth=-2.51%
smargin=10.22%
sdilution=-0.19%
projearning_yield=6.41%
earning_excl_yield=5.34%
div_ratio=50.33%
bb_ratio=38.66%
sh_payout_ratio=88.99%
PS=4.46
price=104
ratio=83.63%
sratio=25.07%
sratiopaid=25.07%
ratioConsens=1.15
turnover=47.24%
cfmargin=16.90%
rdmargin=20.12%
scfmargin=5.37%
quoteccy=USD
quotefx=100.00%
ratiopaid=83.63%
dt=2023-03-17
assetgrowth=2.25%
dlnfx=0